| |
P.falciparum
Genome Sequencing Consortium
The P.falciparum
Genome Sequencing Consortium is a collaboration among 3 sequencing centres:
The Sanger Centre (U.K.), The Institute for Genomic Research/Naval Medical
Research Institute (U.S.A.), and Stanford University (U.S.A.). Look
for progress reports, news, and meeting information, and many useful
links. |
|
|
Mapping
Malaria Risk in Africa
The MARA/ARMA collaboration was initiated to provide
an Atlas of malaria for Africa. MARA/ARMA provides a great number of
maps that are based on Remote Sensing. |
| |
Malaria
Vaccine Initiative (MVI)
The MVI was created through a grant of the Bill and Melinda Gates Foundation
to PATH (Program for Appropriate Technology in Health). The objective
of the MVI will be to significantly accelerate the clinical development
of promising malaria vaccine candidates. The MVI is expected to lead
to field trials of one or more vaccine candidates; coordinate its efforts
with malaria vaccine programs at various organizations and agencies;
and identify gaps in current research efforts and apply resources to
advance promising malaria vaccine candidates. |
|
|
ACTMalaria
- Asia
The Asian Collaborative Training Network for Malaria (ACTMalaria) is
an intercountry initiative between Bangladesh, Cambodia, China (Yunnan
Province), Indonesia, Lao PDR, Malaysia, Myanmar, Thailand, and Vietnam:
1) To collect, develop, and disseminate training materials and to implement
practical training courses to meet the needs of malaria control programs
in southeast Asia and the Mekong valley.
2) To improve communication between these countries on malaria control
problems affecting their common borders. |
| |
Medicines
for Malaria Venture (MMV)
WHO's
new MMV is a joint public-private sector initiative which aims to develop
antimalarial drugs and drug combinations for distribution in poor countries.
|
|
|
Regional
Malaria Control Programme in Cambodia, Laos and Vietnam
This is
a European Community Regional Malaria Control Programme.
|
| |
Roll
Back Malaria (RBM) Partnership
The RBM initiative was announced by WHO in May 1998. It is a global
strategy to improve health systems with the goal of a 50% reduction
in malaria deaths by 2010. This will be achieved by:
*increasing speedy access for people
to effective treatment and means of protection from mosquito bites
*enabling national authorities and
non-governmental organizations to combat malaria intensifying efforts
*developing new products for the
prevention and treatment of malaria. |
|
|
African
Malaria Vaccine Testing Network
(AMVTN)
The AMVTN is
a non-profit network established in 1995 in Arusha, Tanzania. Its objective
is to provide a forum for scientists and policy makers involved in the
planning, coordination, and execution of malaria vaccination trials
in Africa.
|
| |
Multilateral
Initiative on Malaria (MIM)
The
MIM is an alliance of organisations & individuals concerned with
malaria. It aims to maximise the impact of scientific research against
malaria in Africa, by facilitating global collaboration & coordination. |
|
|
Malaria
Research and Reference Reagent Resource Center
(MR4)
sponsored
by NIAID
parasite,
vector, and host cell reagents
|
